Tau Therapeutics

	Tau Therapeutics Files IND to Begin Phase Ib Clinical Trial in Glioblastoma Multiforme January 31, 2011
	Tau Therapeutics Raises Largest Fundraising Round: $4.2 Million to Fund Phase Ib GBM Trial January 31, 2011
	Tau Therapeutics LLC Awarded Qualifying Therapeutic Discovery Project Grant November 1, 2010
	Roche Supplies Tau Therapeutics with Over $900,000 of Mibefradil August 31, 2010
	Tau Therapeutics LLC Expands Corporate Headquarters in Charlottesville, VA August 1, 2010
	Tau Founder Dr. Timothy L. Macdonald Named UVA Patent Foundation's 2010 Edlich-Henderson Inventor of the Year April 5, 2010
	Lead Brain Cancer Specialists Dr. David Reardon and Dr. Mark Gilbert Join Tau Therapeutics' Clinical Advisory Team April 1, 2010
	Tau Therapeutics Expands Management Team to Include CFO, General Counsel and Analyst February 15, 2010
	Dr. David Schiff Joins Tau Therapeutics as PI for Brain Cancer Trial February 10, 2010
	Tau Theraputics Receives FDA Orphan Drug Approval in Glioblastoma Multiforme August 25, 2009
	Tau Therapeutics Receives FDA Orphan Drug Approval in Pancreatic Cancer October 18, 2008
	Dr. Paul Sartori Joins Tau Therapeutics' Business Advisory Team May 1, 2008
	Tau Therapeutics Receives FDA Orphan Drug Approval in Ovarian Cancer June 17, 2007
	Tau Therapeutics Partners with Duke University and Accelerate Brain Cancer Cure Foundation April 20, 2007